Product NDC: | 16571-120 |
Proprietary Name: | Ciprofloxacin |
Non Proprietary Name: | CIPROFLOXACIN HYDROCHLORIDE |
Active Ingredient(s): | 3.5 mg/mL & nbsp; CIPROFLOXACIN HYDROCHLORIDE |
Administration Route(s): | TOPICAL |
Dosage Form(s): | SOLUTION/ DROPS |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 16571-120 |
Labeler Name: | PACK Pharmaceuticals, LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA077689 |
Marketing Category: | ANDA |
Start Marketing Date: | 20080320 |
Package NDC: | 16571-120-50 |
Package Description: | 48 BOTTLE in 1 CASE (16571-120-50) > 5 mL in 1 BOTTLE |
NDC Code | 16571-120-50 |
Proprietary Name | Ciprofloxacin |
Package Description | 48 BOTTLE in 1 CASE (16571-120-50) > 5 mL in 1 BOTTLE |
Product NDC | 16571-120 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | CIPROFLOXACIN HYDROCHLORIDE |
Dosage Form Name | SOLUTION/ DROPS |
Route Name | TOPICAL |
Start Marketing Date | 20080320 |
Marketing Category Name | ANDA |
Labeler Name | PACK Pharmaceuticals, LLC |
Substance Name | CIPROFLOXACIN HYDROCHLORIDE |
Strength Number | 3.5 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Quinolone Antimicrobial [EPC],Quinolones [Chemical/Ingredient] |